Beijing Strong Biotechnologies Inc Cash Flow-to-Debt Ratio
Beijing Strong Biotechnologies Inc cash flow-to-debt ratio. Beijing Strong Biotechnologies Inc (300406) has a Cash Flow-to-Debt Ratio of 0.14x as of September 2025, meaning its operating cash flow of CN¥182.86 Million could theoretically repay 0% of its total liabilities (CN¥1.30 Billion) in one year. Check 300406 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Beijing Strong Biotechnologies Inc (2011–2024)
Cash flow-to-debt ratio of Beijing Strong Biotechnologies Inc from 2011 to 2024. Historical debt coverage capacity for Beijing Strong Biotechnologies Inc across 14 annual periods. Check cash flow reinvestment rate of Beijing Strong Biotechnologies Inc to assess the company's total reinvestment commitment from operating cash flow.
Beijing Strong Biotechnologies Inc Cash Flow-to-Debt Ratio by Year (2011–2024)
Beijing Strong Biotechnologies Inc cash flow-to-debt ratio by year from 2011 to 2024. Year-by-year debt coverage analysis for Beijing Strong Biotechnologies Inc. For the full cash flow conversion analysis, see Beijing Strong Biotechnologies Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.43x | CN¥614.01 Million | CN¥1.44 Billion | ▲ +4.9% |
| 2023 | 0.41x | CN¥590.15 Million | CN¥1.45 Billion | ▲ +37.7% |
| 2022 | 0.29x | CN¥396.17 Million | CN¥1.34 Billion | ▲ +21.5% |
| 2021 | 0.24x | CN¥341.10 Million | CN¥1.41 Billion | ▲ +6.5% |
| 2020 | 0.23x | CN¥123.06 Million | CN¥540.20 Million | ▼ -77.9% |
| 2019 | 1.03x | CN¥188.60 Million | CN¥183.09 Million | ▼ -34.6% |
| 2018 | 1.58x | CN¥256.15 Million | CN¥162.52 Million | ▲ +88.5% |
| 2017 | 0.84x | CN¥207.91 Million | CN¥248.65 Million | ▼ -71.4% |
| 2016 | 2.93x | CN¥243.21 Million | CN¥83.09 Million | ▲ +77.7% |
| 2015 | 1.65x | CN¥142.59 Million | CN¥86.56 Million | ▼ -39.7% |
| 2014 | 2.73x | CN¥156.94 Million | CN¥57.44 Million | ▼ -17.3% |
| 2013 | 3.30x | CN¥147.19 Million | CN¥44.57 Million | ▲ +23.2% |
| 2012 | 2.68x | CN¥125.49 Million | CN¥46.81 Million | ▲ +63.7% |
| 2011 | 1.64x | CN¥45.90 Million | CN¥28.04 Million | — |